The global Chlamydia Infection Diagnostics and Therapeutics Market is expanding steadily, driven by the increasing global prevalence of sexually transmitted infections (STIs), expanding routine screening programs, and technological advancements in rapid molecular testing. Valued at USD 1.1 Billion in 2023, the market is projected to reach USD 2.3 Billion by the end of 2034, growing at a...